New Weight-Loss Pill Attracts Men and other First-Time Customers
The telehealth landscape is currently witnessing a massive transformation in how patients manage their metabolic goals. This shift goes…
-
-
What Most Wegovy Tracking Apps Get Wrong About the Pill
As oral Wegovy becomes more common, many people turn to tracking apps to make sense of how semaglutide behaves…
-
Serena Williams Takes the Super Bowl Spotlight to Reframe the GLP-1 Health Conversation
Serena Williams is stepping onto the Super Bowl stage this year with a message that goes beyond sports, branding,…
-
GLP-1 Breakthroughs Offer a New Shield for Your Memory
Modern medical studies are currently proving that our brain health is closely tied to our metabolism. This discovery goes…
-
Roche’s Experimental Obesity Drug Shows Powerful Weight Loss in Phase II Trial
Roche has reported strong Phase II clinical results for its experimental obesity medicine CT-388, raising optimism about the future…
-
How GLP-1 Medications Are Changing the Future of Heart Health
GLP-1 medications have gained attention for weight loss, but research now highlights their powerful role in heart health. These…
-
FDA Delay Pushes Eli Lilly’s Oral Weight-Loss Pill to April, Shaking Investor Confidence
Eli Lilly’s experimental oral weight-loss drug orforglipron has encountered a regulatory delay, pushing back what investors hoped would be…
-
Thinking About the Wegovy Pill? Here’s What to Know
The FDA has approved a daily pill version of Wegovy, giving patients another way to use one of the…
-
Diabetes Drugs Show Promise in Fighting Addiction and Boosting Mental Health
A new review in JAMA Psychiatry suggests that glucagon-like peptide-1 (GLP-1) therapies could offer hope for treating addiction and…
-
New Weight-Loss Pill Offers Hope, Convenience for Millions in Wisconsin
A new weight-loss pill is poised to change obesity treatment in the United States. The first oral GLP-1 medication…
